Technology Offerings

New Tumor-Selective Boron Compounds for Cancer Therapy

The offer describes the synthesis of new tumor-selective boron compounds for application in boron neutron capture therapy (BNCT).

Further Information: PDF

GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: 0351-8734 1725

Contact
Jens Voigt

Comments (0)

Write a comment